Pathologists and radiologists are leading the way in the use of artificial intelligence (AI) to find and track cancer. Machine learning could lay the foundation for using AI more broadly to advance cancer diagnosis and choice of treatment.

by Stephen Ornes

Policy Matters

Cancer has a disproportionate impact on disadvantaged and minority groups. The AACR 2020 by 2020 initiative is a step toward closing the gap.

by Michael A. Caligiuri, MD

Forward Look

Neurosurgeon Frederick F. Lang discusses virus-powered cancer treatments.

by Sue Rochman

Forward Look

Including patients with HIV is part of a larger effort to broaden cancer clinical trial eligibility.

by Andy Kopsa

Forward Look

Research findings could help improve personalized treatments for lung cancer patients.

by Stephen Ornes

Immunotherapy drugs have led to long-lasting remissions for some cancer patients with advanced disease. They also come with a new and diverse array of side effects.

by Kate Yandell

Forward Look

Study findings suggest opportunities for preventing endometrial cancer.

by Deborah Abrams Kaplan

Many older adults with cancer place more importance on maintaining their independence and cognitive abilities than on living as long as possible.

by Cheryl Platzman Weinstock

Many cancer clinical trials do not track what proportion of enrolled patients are obese, a study finds. These patients may be underrepresented in research.

by Cici Zhang

Researchers are exploring whether wearable personal activity monitors could provide doctors with a more complete picture of cancer patients' well-being.

by Brad Jones